Biovie Inc (BIVI) Directors and Executive Officers

Officers & Directors

Jim Lang
Director

Robert Hariri
Director

Richard J. Berman
Director

Sigmund Rogich
Director

Michael Sherman
Director

EisnerAmper LLP
We have served as the Company s auditor since;

Cuong Do
Chief Executive Officer

Joanne Wendy Kim
Chief Financial Officer ,

Biovie Inc currently has 13 employees.

News about Biovie Inc Key Personnel

Navigating Financial Currents: BioVie Inc.s Strategic Moves Amidst Challenges

In the ever-evolving landscape of healthcare, emerging companies like BioVie Inc. find themselves on a precarious tightrope, balancing innovative aspirations against stark financial realities. Recently, BioVie (Nasdaq: BIVI), a clinical-stage biopharmaceutical firm specializing in therapies for chronic debilitating conditions—including liver disease and neurological disorders—announced significant financial maneuvers aimed at bolstering its future, yet the challenges it faces underline the complexities burgeoning biotech companies must navigate. Recent Developments and Financial OverviewOn October 22, 2024, BioVie disclosed the successful closing of a registered direct offering of 4,443,000 shares, price...

BioVie Inc: Navigating a Long COVID Trial Amidst Financial Struggles

The Formation of Advisory Board and Financial Struggles: Assessing the Impact on BioVie Inc s Long COVID Trial
BioVie Inc, a prominent pharmaceutical company, has recently announced the formation of an Advisory Board to guide and accelerate their groundbreaking Bezisterim long COVID Phase 2b trial. This trial has garnered significant support from the U.S. Department of Defense, highlighting the critical nature of BioVie s research in addressing the long-term effects of COVID-19.
Simultaneously, the company s financial performance has faced challenges, as recorded in a press release statement. BioVie Inc has reported a cumulative net loss of $-37 million during the twelve months ending in the third qu...